Amanda Pedersen

News Editor at Medical Device and Diagnostic Industry (MDDI)

MD+DI Senior Editor. I have covered medtech news for 17 years. My 5-year plan is to get to level 50 on Pokémon Go. All opinions expressed here are my own.

Featured in: Favicon

mddionline.com

linkedin.com Favicon

newsbreak.com Favicon

designnews.com Favicon

plasticstoday.com Favicon

packagingdigest.com Favicon

powderbulksolids.com Favicon

batterytechonline.com Favicon

ourcommunitynow.com Favicon

thomsonreuters.com + 2 more

Articles

Elon Musk's Neuralink Raises $650M to Accelerate Brain-Computer Interface Development

3 days ago | mddionline.com | Amanda Pedersen

Elon Musk’s brain-computer interface startup, Neuralink, has raised $650M in a series E financing round. “This funding helps us bring our technology to more people — restoring independence for those with unmet medical needs and pushing the boundaries of what’s possible with brain interfaces,” Neuralink noted in a blog post.
CMR Surgical Seeks a Buyer

4 days ago | mddionline.com | Amanda Pedersen

CMR Surgical, a UK-based surgical robotics company, has reportedly put itself up for sale, seeking a valuation of $4B. At a GlanceThe company reportedly hired advisors recently to begin the sale process. CMR Surgical competes with large US-based companies like Intuitive Surgical. The VC arm of GE HealthCare is among the company's investors.
When Medical Device Recalls Are a Good Thing

4 days ago | mddionline.com | Amanda Pedersen

Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.
Medtech's New Reality

5 days ago | mddionline.com | Amanda Pedersen

This week in Pedersen's POV, our senior editor explores the forces at play that are prompting big strategy shifts for some medtech giants. Breaking up is hard to do in medtech, too. Or is it? There’s a shift in the medtech winds that serves as a reflection of broader economic pressures and market realities. This shift is playing out in the form of significant strategic realignments at larger medical device companies.
Medtronic Splits, Boston Scientific Exits TAVR, J&J Loses Big

1 week ago | mddionline.com | Amanda Pedersen

The decision is expected to create a more focused company with a more simplified portfolio in high-margin growth markets while creating an independent, scaled leader in diabetes. Boston Scientific is discontinuing sales of its Acurate TAVR platform, citing tougher regulatory requirements and poor clinical performance. Recent studies have shown that Acurate Neo2 performed worse than competing valves from Medtronic and Edwards Lifesciences.
Hologic Declines $16B Buyout Offer from TPG & Blackstone

1 week ago | mddionline.com | Amanda Pedersen

Tuesday afternoon, the Financial Times reported that TPG and Blackstone offered $16B to take Hologic private but that the Marlborough, MA-based company rejected the offer. Hologic is a medtech company focused on women's health, including mammography technology.
Medtronic Projects $350M Tariff Hit

1 week ago | mddionline.com | Amanda Pedersen

Medtronic is bracing for a $200M-$350M net tariff impact in its fiscal year 2026, executives said during the company’s fiscal fourth quarter ‘25 earnings call. “...We are extremely focused on mitigating actions,” CEO Geoff Martha said, according to Seeking Alpha transcripts of the call. The company expects the impact from tariffs to be minimal in its fiscal first quarter, 10% in the second quarter, 30% in the third quarter, and 60% in the fourth quarter.
Medtech Trivia Tuesday Goes Old School

1 week ago | mddionline.com | Amanda Pedersen

Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.
Auxilium's NeuroSpan Bridge Enters Clinical Trial for Nerve Repair

2 weeks ago | mddionline.com | Amanda Pedersen

The NeuroSpan Bridge is designed to improve nerve regeneration and restore function in patients with nerve injuries. At a GlanceThe pivotal trial, Neurospan-1, aims to enroll 80 patients across the United States. Earlier this year, Auxilium's work in microgravity bioprinting produced implantable medical devices in space. Auxilium Biotechnologies has enrolled the first patient in its clinical trial evaluating the safety and efficacy of a device designed to improve nerve regeneration.
Medtronic to Split Off Diabetes Unit

2 weeks ago | mddionline.com | Amanda Pedersen

Medtronic plans to separate its diabetes business into a new company. Medtronic is exiting the diabetes business. The medtech giant said the decision to separate its diabetes business will create a more focused Medtronic, with a more simplified portfolio in high-margin growth markets, while creating an independent, scaled leader in diabetes. According to Medtronic, the new company will be the only diabetes company to sell a complete ecosystem to address intensive insulin management.